clot-dissolving drug

Also found in: Medical.

clot-dissolving drug:

see thrombolytic drugthrombolytic drug
or clot-dissolving drug,
substance, such as streptokinase or tissue plasminogen activator (tPA), that causes the breakdown of blood clots (see thrombosis) that obstruct the flow of blood through the vessels.
..... Click the link for more information.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved.
References in periodicals archive ?
Until recently, ischemic strokes--the type resulting from a clot that blocks blood flow--were treated with a clot-dissolving drug called tissue plasminogen activator (tPA).
Sayed Mohammed Jaffar, 67, was administered a clot-dissolving drug and was discharged within three days.
When King learned the FDA was delaying approval of tPA, he launched a public relations campaign that, along with Life Extension, was harshly critical of the FDA holding back approval of this clot-dissolving drug.
Next, he inserted intravenous (IV) lines in both his arms and self-administered medications such as aspirin, blood thinners, painkillers and tenecteplase, a clot-dissolving drug.
Doctors couldn't administer the clot-dissolving drug tPA until they brought Jennifer's blood pressure down.
It's a clot-dissolving drug given intravenously to some stroke patients.
The findings represent the first new treatment for acute ischemic stroke in 20 years since the development of the clot-dissolving drug tPA, says Jeffrey Saver, MD, director of the UCLA Stroke Center.
The new procedure is expected to help those among the estimated 630,000 American stroke victims each year who have blockages in the larger blood vessels of the brain, where the clot-dissolving drug tPA may not be effective.
During an acute stroke, physicians must quickly evaluate and diagnose the patient as soon as possible to determine if patients are eligible to receive the clot-dissolving drug recombinant tissue plasminogen activator (tPA), which must be given 4.5 hours within hours of symptom onset.
In the end she was treated with a clot-dissolving drug and by widening a large vein in her hip.